These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3007737)

  • 1. Roles for Ca++ and cyclic AMP in mediating the cardiotonic actions of isomazole (LY175326).
    Hayes JS; Bowling N; Pollock GD; Robertson DW
    J Pharmacol Exp Ther; 1986 Apr; 237(1):18-24. PubMed ID: 3007737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis for the cardiovascular activities of amrinone and AR-L57.
    Hayes JS; Bowling N; Boder GB; Kauffman R
    J Pharmacol Exp Ther; 1984 Jul; 230(1):124-32. PubMed ID: 6086873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis for the in vitro and in vivo cardiotonic activities of AR-L100.
    Hayes JS; Wyss VL; Wilson HC; Robertson DW; Kauffman RF
    J Pharmacol Exp Ther; 1986 Nov; 239(2):375-81. PubMed ID: 3021955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphodiesterase isozyme inhibition, activation of the cAMP system, and positive inotropy mediated by milrinone in isolated guinea pig cardiac muscle.
    Silver PJ; Harris AL; Canniff PC; Lepore RE; Bentley RG; Hamel LT; Evans DB
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):530-40. PubMed ID: 2470989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced contractile response and protein kinase activation to threshold levels of beta-adrenergic stimulation in hyperthyroid rat heart.
    Guarnieri T; Filburn CR; Beard ES; Lakatta EG
    J Clin Invest; 1980 Apr; 65(4):861-8. PubMed ID: 6102099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of LY175326: a potent cardiotonic agent with vasodilator activities.
    Hayes JS; Pollock GD; Wilson H; Bowling N; Robertson DW
    J Pharmacol Exp Ther; 1985 May; 233(2):318-26. PubMed ID: 3999023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic GMP-dependent protein kinase activation in the absence of negative inotropic effects in the rat ventricle.
    MacDonell KL; Diamond J
    Br J Pharmacol; 1997 Dec; 122(7):1425-35. PubMed ID: 9421291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of sulmazole (AR-L 115 BS) on contractile force and cyclic AMP levels in canine ventricular muscle: comparison with MDL 17,043.
    Endoh M; Yanagisawa T; Morita T; Taira N
    J Pharmacol Exp Ther; 1985 Jul; 234(1):267-73. PubMed ID: 2989507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the positive inotropic action of a novel cardiotonic agent, MCI-154, involve mechanisms other than cyclic AMP?
    Kitada Y; Narimatsu A; Suzuki R; Endoh M; Taira N
    J Pharmacol Exp Ther; 1987 Nov; 243(2):639-45. PubMed ID: 2824754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of (-)-norepinephrine and of (+/-)-isoproterenol on cardiac contraction, an uptake phenomenon.
    Korth M; Schmied R
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1164-71. PubMed ID: 2849663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency modulation of the inotropic action of isoproterenol in mouse heart.
    Barovsky K; Gross SR
    J Pharmacol Exp Ther; 1981 May; 217(2):314-25. PubMed ID: 6262482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of verapamil on myocardial contractility, cardiac adenosine 3,'5'-monophosphate and heart phosphorylase.
    Shanfeld J; Hess ME; Levine NR
    J Pharmacol Exp Ther; 1975 May; 193(2):317-26. PubMed ID: 167148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphodiesterase inhibition by naloxone augments the inotropic actions of beta-adrenergic stimulation.
    Park WK; Chang CH; Chae JE; Kim MH; Cho YL; Ahn DS
    Acta Anaesthesiol Scand; 2009 Sep; 53(8):1043-51. PubMed ID: 19572940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient activation of cyclic AMP-dependent protein kinase and phosphorylase during the cardiac cycle in the canine myocardium in situ and the effect of propranolol.
    Krause EG; Bartel S; Ameln I; Beyerdörfer I; Freier W; Reese D
    Biomed Biochim Acta; 1987; 46(8-9):S482-6. PubMed ID: 2829869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the cyclic AMP antagonist, Rp-cAMPS, to distinguish between cyclic AMP-dependent and cyclic AMP-independent contractile responses in rat ventricular cardiomyocytes.
    Bell D; McDermott BJ
    J Mol Cell Cardiol; 1994 Nov; 26(11):1439-48. PubMed ID: 7897668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of cyclic adenosine 3', 5'-monophosphate and calcium in the regulation of contractility and glycogen phosphorylase activity in guinea pig papillary muscle.
    Dobson JG; Ross J; Mayer SE
    Circ Res; 1976 Sep; 39(3):388-95. PubMed ID: 182412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel cardiotonic agent SCH00013 acts as a Ca++ sensitizer with no chronotropic activity in mammalian cardiac muscle.
    Sugawara H; Endoh M
    J Pharmacol Exp Ther; 1998 Oct; 287(1):214-22. PubMed ID: 9765340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate dependence of isoproterenol-stimulated phosphorylase a formation in mouse heart.
    Barovsky K; Gross SR
    J Pharmacol Exp Ther; 1981 May; 217(2):326-32. PubMed ID: 6262483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic and regional hemodynamic effects of isomazole in awake dogs with congestive heart failure.
    Imai N; Liang CS; Stone CK; Hayes JS; Hood WB
    J Pharmacol Exp Ther; 1987 Apr; 241(1):20-6. PubMed ID: 3572783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of isomazole on force of contraction and phosphodiesterase isoenzymes I-IV in nonfailing and failing human hearts.
    Bethke T; Klimkiewicz A; Kohl C; von der Leyen H; Mehl H; Mende U; Meyer W; Neumann J; Schmitz W; Scholz H
    J Cardiovasc Pharmacol; 1991 Sep; 18(3):386-97. PubMed ID: 1720839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.